ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
| Price | $18.58 |
|---|---|
| Market cap | $1.9B |
| Sector | Industrials |
| Industry | Specialty Business Services |
| Exchange | NASDAQ |
| 52-week range | 17.3-23.21 |
| Beta | 0 |
Explore ADRX's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.